The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients | NCT07718204

NCT07718204

Overview

NCT ID: NCT07718204
Lead Sponsor: Nationwide Children's HospitalOTHER
Official Title: MedMemos: An Intervention to Promote Medication Adherence in Pediatric Allogenic Hematopoietic Stem Cell Transplantation
Brief Summary: The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:

Is the MedMemos intervention acceptable to patients and families?

Is the MedMemos intervention feasible for patients, families, and healthcare providers?

Does MedMemos help patients and families take their medications better?

Participants will be asked to complete surveys, attend 4 intervention sessions, and use an electronic box or pill bottle to store their medications in.
Conditions: Hematopoietic Cell Transplant

Ages Eligible for Study: Child (0-17)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)

Child is 0-12 years of age

At the time of recruitment child is still in the hospital for PAHCT

Child's primary caregiver is responsible for administering medical care and is willing to give consent to participate

Child is prescribed an oral medication regimen at discharge

Exclusion Criteria:

Caregiver does not speak English, Spanish, or Arabic

Caregiver is not available to provide written permission for the child's participation

EMR or medical team report of the caregiver's cognitive status precludes completion of questionnaires

The child's medical status or condition precludes completion of the study questionnaires as determined by the physician or caregiver

Caregiver is unwilling to store medication in an electronic monitor

Central Contacts: Ahna LH Pai, PhDContact
Ahna.Pai@nationwidechildrens.org(614) 938-1601